Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170802035464N2Phase 3Completed
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Ondansetron, Dexamethasone and Placebo (3 arms). Primary endpoints: Headache intensity at 12 hours, Headache intensity at 24 hours and 1 more. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170802035464N2.